Ligand Pharmaceuticals, Inc. (LGND)
191.64
+2.64
(+1.40%)
USD |
NASDAQ |
Feb 25, 11:50
Ligand Pharmaceuticals EPS Diluted (Quarterly) : 5.685 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| ADMA Biologics, Inc. | 0.1489 |
| Johnson & Johnson | 2.098 |
| Elanco Animal Health, Inc. | -0.5554 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 117.27M |
| Revenue (Quarterly) | 115.46M |
| Total Expenses (Quarterly) | -1.812M |
| Enterprise Value | 3.506B |
| Gross Profit Margin (Quarterly) | 89.70% |
| Earnings Yield | 1.08% |
| Operating Earnings Yield | 0.76% |
| Normalized Earnings Yield | 0.1178 |